Yan Tai Selected Research

prostaglandin-inositol cyclic phosphate

1/2022	Nrf2 Activation Mediates Antiallodynic Effect of Electroacupuncture on a Rat Model of Complex Regional Pain Syndrome Type-I through Reducing Local Oxidative Stress and Inflammation.
1/2022	Electroacupuncture Ameliorates Mechanical Allodynia of a Rat Model of CRPS-I via Suppressing NLRP3 Inflammasome Activation in Spinal Cord Dorsal Horn Neurons.
1/2021	Gene Expression Profiling of Contralateral Dorsal Root Ganglia Associated with Mirror-Image Pain in a Rat Model of Complex Regional Pain Syndrome Type-I.
5/2020	Expression profiling of spinal cord dorsal horn in a rat model of complex regional pain syndrome type-I uncovers potential mechanisms mediating pain and neuroinflammation responses.
1/2020	Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats.
1/2019	Transcriptome profiling of dorsal root ganglia in a rat model of complex regional pain syndrome type-I reveals potential mechanisms involved in pain.
1/2019	TRPV1 Channel Contributes to the Behavioral Hypersensitivity in a Rat Model of Complex Regional Pain Syndrome Type 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Tai Research Topics

Disease

15	Pain (Aches) 02/2022 - 01/2016
8	Inflammation (Inflammations) 02/2022 - 01/2016
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2011
8	Hyperalgesia 01/2022 - 01/2016
5	Neoplasms (Cancer) 01/2022 - 02/2011
3	Hypersensitivity (Allergy) 01/2020 - 01/2019
3	Ischemia 01/2020 - 01/2019
3	Gout 01/2020 - 01/2018
2	Allergic Contact Dermatitis 02/2022 - 11/2019
2	Chronic Pain 01/2022 - 01/2022
2	Arthritis (Polyarthritis) 01/2020 - 01/2018
2	Reperfusion Injury 01/2018 - 12/2012
1	Contact Dermatitis (Eczema, Contact) 02/2022
1	Neuroinflammatory Diseases 01/2022
1	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 01/2022
1	Postoperative Pain 01/2022
1	Edema (Dropsy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hepatitis 01/2020
1	Hyperemia 01/2020
1	Neuralgia (Stump Neuralgia) 01/2019
1	Hyperthermia 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Liver Neoplasms (Liver Cancer) 03/2017
1	Hyperpigmentation 01/2017
1	Lentigo (Lentiginosis) 01/2017
1	Melanosis (Freckles) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Acute Lung Injury 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 01/2016
1	Acute Pain 01/2016
1	Primary Graft Dysfunction 12/2012

Drug/Important Bio-Agent (IBA)

7	prostaglandin-inositol cyclic phosphateIBA 01/2022 - 01/2019
4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2019
3	InflammasomesIBA 01/2022 - 01/2020
2	AllergensIBA 02/2022 - 11/2019
2	AntioxidantsIBA 01/2022 - 01/2020
2	immune RNA (I-RNA)IBA 01/2021 - 01/2019
2	TRPA1 Cation ChannelIBA 01/2020 - 01/2019
2	Uric Acid (Urate)IBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2015
2	Interleukin-33IBA 01/2020 - 11/2016
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2020 - 01/2018
2	CytokinesIBA 01/2019 - 05/2012
2	MicroRNAs (MicroRNA)IBA 03/2017 - 11/2015
1	ProteomeIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	LigandsIBA 01/2022
1	CateninsIBA 01/2022
1	TransglutaminasesIBA 01/2020
1	EucalyptolIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Capsaicin (Zostrix)FDA Link 01/2020
1	AnkyrinsIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	CationsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Vasoconstrictor AgentsIBA 01/2019
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2019
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	Colchicine FDA LinkGeneric 01/2018
1	Opioid Receptors (Opioid Receptor)IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Pharmaceutical PreparationsIBA 03/2017
1	Cisplatin (Platino)FDA LinkGeneric 03/2017
1	hydroquinone (Esoterica)FDA Link 01/2017
1	Transient Receptor Potential ChannelsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	urushiolIBA 11/2016
1	Neutralizing AntibodiesIBA 11/2016
1	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 01/2016
1	TransducinIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2016
1	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2012
1	Dinoprostone (PGE2)FDA Link 05/2012
1	Amino Acids FDA Link 02/2011
1	Cell-Penetrating PeptidesIBA 02/2011
1	Biological ProductsIBA 02/2011
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2011

Therapy/Procedure

3	Electroacupuncture 01/2022 - 01/2018
2	Therapeutics 01/2022 - 01/2018
2	Drug Therapy (Chemotherapy) 03/2017 - 11/2015
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Anesthesia 01/2020
1	Organ Transplantation 01/2018
1	Liver Transplantation 12/2012